Q4 Pharma Earnings Preview: GSK, Lilly, Sanofi And AstraZeneca

 
• By Kevin Grogan, Jessica Merrill, and Mandy Jackson

GlaxoSmithKline will update investors on strategy after completing its Tesaro acquisition. Lilly may have guidance updates following its Loxo acquisition and Lartruvo setback news. Sanofi investors await a pair of new approvals, and AstraZeneca faces investors for the first time since the departure of Chief Medical Officer Sean Bohen and establishing a new organizational structure.

4th quarter computer key on key board

More from Earnings

More from Business